News

Kyma Restaurant Expands with New Location at ModernHaus SoHo

Kyma Restaurant Expands with New Location at ModernHaus SoHo

Kyma Restaurant's Exciting New Chapter at ModernHaus SoHo

The renowned Greek restaurant, Kyma, is taking a significant step forward by leasing its fourth location in the bustling heart of SoHo. This new restaurant will reside in an expansive space totaling over 10,000 square feet at the ModernHaus SoHo Hotel. The hotel, known for its modern design and laid-back atmosphere, provides an ideal backdrop for Kyma's distinctive culinary brand.

Prime Location with Promising Potential

Situated in a competitive dining corridor, the chosen location had attracted numerous prospective tenants. However, Kyma stood out due to its exceptional reputation for providing top-notch Mediterranean culinary experiences. The decision-making came down to the restaurant's ability to deliver not only exquisite seafood and traditional dishes but also to cultivate a warm atmosphere reminiscent of true Greek hospitality.

Reputation and Recognition

Kyma has already earned accolades for its other locations in Flatiron, Roslyn, and Hudson Yards, all of which are recognized by the Michelin Guide. Moving into this sought-after SoHo neighborhood, renowned for its dynamic mix of high-end retail, art galleries, and extraordinary restaurants, presents Kyma with a fantastic opportunity to expand its audience. Scheduled to open in 2026, the new venue promises to enhance the local dining scene with its unique offerings and ambiance.

A Thriving Dining Market

The current market conditions in New York have proven to be highly favorable for restaurants. James Famularo, of Meridian Capital Group's Retail Leasing team, highlights that many previously vacant spaces are now being filled rapidly. He commented on how landlords are increasingly selective, focusing on bringing in tenants who can assure success based on their track record. Famularo expressed that Kyma’s impressive reputation made them a perfect fit for this iconic SoHo location.

Welcoming Feedback from Thor Equities

Joe Sitt, Chairman of Thor Equities Group, conveyed his excitement about welcoming Kyma to the ModernHaus SoHo. He acknowledged the restaurant's commitment to excellence and how it aligns perfectly with the vision of establishing the hotel and its facilities as standout destinations in the area. This collaboration signals an exciting evolution for both Kyma and ModernHaus, ready to captivate both locals and visitors alike.

About Kyma and Thor Equities

Kyma, cherished for its authentic Mediterranean flavors and focus on fresh seafood, is set to bring an inviting atmosphere to its new location. Meanwhile, Thor Equities Group is recognized as a leader in the development and management of various asset types, including residential, office, and mixed-use properties. With a portfolio valued at approximately $20 billion and assets around the globe, Thor continues to push the boundaries of innovation in real estate.

Connecting with Kyma

For those interested in learning more about Kyma's journey and offerings, the restaurant’s mission revolves around sharing incredible culinary experiences derived from its Greek roots. By expanding into SoHo, they aspire to connect with a wider audience and share their food philosophy, showcasing the rich flavors of the Mediterranean.

Frequently Asked Questions

Where will Kyma's new location be established?

Kyma's new restaurant will be located at the ModernHaus SoHo Hotel on Grand Street.

When is Kyma's SoHo restaurant expected to open?

The opening is projected for the year 2026.

What makes Kyma unique among other dining options?

Kyma is known for its dedication to authentic Mediterranean dishes with a focus on fresh seafood, complemented by a welcoming atmosphere.

Who represented Kyma in this leasing agreement?

Justin Bustamante, from the Meridian Capital Group, represented Kyma during the lease negotiations.

What is the main objective of Thor Equities in this lease?

Thor Equities aims to create standout destinations and enhance the overall appeal of the ModernHaus SoHo as a premier location for dining and leisure.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 0

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Salus Scientific Pioneers Safety at TCT 2026

Updated Category News Views 5

Revolutionizing Occupational Safety in Healthcare Radiation exposure in the medical field: the dull, ominous toll it takes on healthcare professionals, often cloaked in acceptance as a mere occupational hazard. But here's Salus Scientific crashing into the party at TCT 2026 like a seasoned rockstar, demanding we stop accepting the dangers of fluoroscopy-guided procedures...

Continue Reading
HSG's Laser Tech Dazzles at FABTECH 2026

Updated Category News Views 10

Laser Innovations on Display at FABTECH 2026 Listen up, folks—FABTECH 2026 in Vegas is where HSG Laser decided to flaunt their new toys, codenamed TS2 PRO and the mystical AI CutPilot. Now, unless you've been living under a rock, you'll know HSG is all about shaking up the laser cutting scene. They've done it for two decades, and now they're pushing the envelope with...

Continue Reading
Empire Steak House Expands to Delray Beach

Updated Category News Views 38

Steakhouse Kings Bring New York Flavors to Florida When you're talking about steak, the Empire Steak House name carries some serious heft. This isn't just another restaurant chain cashing in on prime cuts; it's a family legacy over 21 years in the making. The Sinanaj Brothers, who honed their skills at Peter Luger in New York, are moving their empire south, landing a...

Continue Reading
HumanView Relaunch: LEAP Group Decodes Customer Signals

Updated Category News Views 14

Understanding Customer Signals Like Never Before Well, here's one for the ol' playbook. The LEAP Group just dusted off their tool, HumanView, like an old car getting a fresh coat of paint and an engine overhaul. It's been rebuilt from the ground up, promising to turn those random blips of online chatter into actionable business insights. Not the same old dashboard mumbo...

Continue Reading
Marengo: Bold Moves in TMB-H Tumor Treatment

Updated Category News Views 8

A New Hope for Tough Tumors? Marengo Therapeutics is stirring up the oncology world with some intriguing Phase 2 results from their STARt-001 clinical trial, revealing invikafusp alfa's potential as a single-agent therapy. This hasn’t been a walk in the park, mind you; we're talking about dealing with TMB-H solid tumors that typically thumb their noses at immune...

Continue Reading
CardVault by Tom Brady Expands to Pittsburgh

Updated Category News Views 4

Tom Brady’s CardVault Hits Pittsburgh’s Historic Strip District Pittsburgh just got another feather in its cap with CardVault by Tom Brady marking its 20th store at The Terminal. As if this city needed more sports excitement! Pittsburgh, with its die-hard Steelers, Penguins, and Pirates fans, snags a premium spot for sports collectibles. A Prime Spot for Serious...

Continue Reading
First Citizens Surprises with Q3 Gains and Buyback Plan

Updated Category News Views 5

Unexpected Third Quarter Tailwinds for First Citizens There are days in this trading gig when a bank I'll barely sneeze at hits out of the park. First Citizens BancShares (NASDAQ:FCNCA) pulled off such a feat, wringing out a third-quarter 2026 performance that beat their own benchmarks. They threw $600 million back to shareholders in repurchased stocks while repaying an...

Continue Reading
Energy Services Expands with FAMCO Acquisition

Updated Category News Views 40

Digging Deeper into Energy Services' Next Move Alright, listen up. Today we're diving into Energy Services of America's latest play. They just wrapped up a juicy acquisition, snagging up FAMCO, a utility contractor from West Virginia, for a cool $6.95 million. It's a mix of cold hard cash and some stock from Energy Services' own treasure chest, with a bit put on hold...

Continue Reading
NEXT Properties Exchange Offers: The Full Breakdown

Updated Category News Views 58

What's the Deal with These Exchange Offers? You know, nothing says 'we're changing things up' like an exchange offer. So what did NEXT Properties do? Well, they laid down two offers for the books on their outstanding 6.950% and 6.390% senior notes, due in 2044 and 2050, respectively. These are getting swapped out for some fresh 7.731% senior sustainability-linked notes...

Continue Reading

Top 5 Most Recently Viewed Articles

Domyn Unveils New Era in Responsible AI for Critical Sectors

Updated Category News Views 480

Introducing Domyn: Redefining AI Solutions for Regulated Industries Domyn has emerged as the new name for iGenius, a pioneer in the realm of Responsible AI, specifically tailored for industries subject to rigorous regulations, such as government, finance, and heavy industry. With a commitment to providing cutting-edge AI solutions, Domyn aims to bridge the gap between...

Continue Reading
Pelican Intl Inc. Strengthens Position in Paddlesport Market

Updated Category News Views 326

Pelican Intl Inc. Expands Assets for Future Growth Renewed stability and a bold vision for long-term growth for the paddlesport market leader with U.S. and Canadian manufacturing operations. Pelican Intl Inc., a newly formed entity, proudly announces the successful acquisition of assets from Pelican International Inc. and Confluence Outdoor Inc. through a court-approved...

Continue Reading
Rocket Lab's Ascendancy in the Global Space Launch Sector

Updated Category News Views 154

Rocket Lab's Rise in the Aerospace and Defense Sector The positive news keeps flowing for Rocket Lab USA, Inc. (NASDAQ: RKLB), a noteworthy player in the aerospace and defense industry. The momentum began with a significant upgrade from analysts at Cantor Fitzgerald, who raised their price target for the company. Recently, Rocket Lab has also been selected by the European...

Continue Reading
Concerns Rise for Customers Bancorp Following Federal Review

Updated Category News Views 126

Customers Bancorp in Hot Water Over Risk Management Failures Customers Bancorp, Inc. (CUBI) has found itself under the magnifying glass as the Federal Reserve drops some sobering news about its risk management and compliance practices. Investors are feeling jittery—especially those nursing heavy losses—as they grapple with unsettling revelations about potential flaws...

Continue Reading
Bristol Myers Secures EC Approval for Innovative Liver Cancer Therapy

Updated Category News Views 232

Bristol Myers' Dual Immunotherapy Gains Approval The European Commission (EC) has granted approval to Bristol Myers Squibb & Co's Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for treating adult patients facing unresectable or advanced hepatocellular carcinoma (HCC), a prevalent form of liver cancer. This is a pivotal advancement in onco-immunotherapy....

Continue Reading